Zami Aberman
Chairman and Co-Chief Executive Officer,
Pluristem Therapeutics
Usman Azam
Chief Executive Officer,
Tmunity Therapeutics
Rita Balice-Gordon
Global Head of Rare and Neurologic Diseases Therapeutic Area,
Sanofi
Ron Bartek
Co-Founder and President,
Friedreich's Ataxia Research Alliance
Amy Butler
President, Biosciences,
Thermo Fisher Scientific
Bradley Campbell
President and Chief Operating Officer,
Amicus Therapeutics
Cindy Collins
President and Chief Executive Officer,
Editas Medicine
Miguel Forte
Chief Executive Officer,
Bone Therapeutics
Kristen Harrington-Smith
VP and Head, CAR-T US,
Novartis Oncology
Michael Hunt
Chief Financial Officer,
ReNeuron
Jerry Kebyl
Head of Cell and Gene Therapy Manufacturing,
MilliporeSigma
Paul Laikind
President and Chief Executive Officer,
ViaCyte
Ann Lee
Senior Vice President and Head of Cell Therapy Development & Operations,
Bristol-Myers Squibb
Bruce Levine
Founding Director, Clinical Cell and Vaccine Production Facility,
Abramson Cancer Center, University of Pennsylvania
John Maslowski
Chief Executive Officer,
Castle Creek Pharmaceuticals
Claudia Mitchell
Senior VP, Product and Portfolio Strategy,
Astellas Pharma
Emile Nuwaysir
President and Chief Executive Officer,
BlueRock Therapeutics
Matt Patterson
Strategic Advisor,
Audentes, an Astellas Company
Isabelle Riviere
Director, Cell Therapy and Cell Engineering Facility,
Memorial Sloan Kettering Cancer Center
Jeff Ross
Chief Executive Officer,
Miromatrix Medical
Mark Rothera
President and Chief Executive Officer,
Orchard Therapeutics
Curran Simpson
Senior Vice President, Product Development, and Chief Technical Officer,
REGENXBIO
Sanjaya Singh
Vice President and Global Head,
Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Research & Development
Bob Smith
Senior Vice President, Global Gene Therapy Business,
Pfizer
Devyn Smith
Chief Operating Officer,
Sigilon Therapeutics
Joe Tarnowski
Senior Vice President, Cell and Gene Therapy Platform,
GlaxoSmithKline
Arthur Tzianabos
President and Chief Executive Officer,
Homology Medicines
Gil Van Bokkelen
President and Chief Executive Officer,
Athersys
Christopher Vann
Chief Operating Officer,
Autolus Therapeutics
Jeffrey Walsh
Former Chief Financial and Strategy Officer,
bluebird bio
Susan Washer
President and Chief Executive Officer,
AGTC
